Development of rabbit monoclonal antibodies for ferret biomarkers.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93025C00013
- Awardee
-
Avantgen Inc. UEI WLNHKNPNT2M7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,497,384
Award facts
- Opportunity
-
- PHS202401 Solicitation number
- Contract value 100% obligated
- $1,497,384.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Original award | $1,497,384 |
About this award
This is a $1,497,384.00 firm fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Avantgen Inc., a small business biotechnology company based in San Diego, California. The contract is for the development of rabbit monoclonal antibodies for use as ferret biomarkers. This contract is not associated with a larger contract vehicle and does not have a set-aside designation. Avantgen Inc. has previously been awarded multiple federal contracts and grants, primarily from NIAID and other National Institutes of Health (NIH) agencies, for the development of diagnostic technologies, therapeutic reagents, and biomedical research tools related to infectious diseases. The work performed under this contract aims to create cutting-edge biotechnology solutions to address complex medical and research challenges.
Quick answers
Who was awarded contract 75N93025C00013?
75N93025C00013 was awarded to Avantgen Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on February 1, 2025.
How much is contract 75N93025C00013 worth?
The government has obligated $1,497,384 on 75N93025C00013.
Was contract 75N93025C00013 competed?
The extent of competition for 75N93025C00013 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award